Global Tumor Ablation Market Set to Reach USD 1.4 Billion by 2029 | MarketsandMarkets™

Advancements in ablation technologies, expanding healthcare access in emerging economies, and strategic investments by global medtech leaders accelerate market momentum

Delray Beach, FL, Jan. 15, 2026 (GLOBE NEWSWIRE) -- The global tumor ablation market, valued at US$0.7 billion in 2023, stood at US$0.8 billion in 2024 and is projected to advance at a resilient CAGR of 10.0% from 2024 to 2029, culminating in a forecasted valuation of US$1.4 billion by the end of the period. The global tumor ablation market is entering a decisive growth phase as healthcare systems worldwide prioritize minimally invasive cancer treatments amid a rising global cancer burden.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=142550258

Market Overview: What Is Driving Growth and Why It Matters Now
What is fueling this acceleration? The primary driver is the increasing incidence of cancer globally, particularly among the rapidly expanding geriatric population. Tumor ablation procedures are widely used in the treatment of liver, lung, kidney, prostate, and bone cancers, offering precision, reduced trauma, and faster recovery compared to conventional surgical approaches.

Why does this matter now for C-suite leaders and healthcare decision-makers? According to the World Health Organization (WHO), cancer accounted for approximately 10 million deaths globally in 2020, with emerging economies across Asia, Africa, and Oceania representing nearly 55% of the 18.1 million diagnosed cases. As healthcare systems confront rising caseloads and cost pressures, tumor ablation technologies are becoming a strategic solution to improve clinical outcomes while optimizing operational efficiency.

Technology Advancements and Clinical Impact: How Innovation Is Shaping Adoption
How are technological advancements influencing market demand? Continuous innovation in probes, electrodes, and generator systems has significantly improved procedural accuracy while minimizing damage to surrounding healthy tissue. These improvements, combined with growing awareness of early cancer detection and favorable reimbursement frameworks in developed markets, are accelerating adoption across hospitals and cancer care centers.

Radiofrequency ablation accounted for the largest share of the market in 2023, supported by established clinical efficacy and widespread availability. Meanwhile, microwave ablation is expected to witness the fastest growth rate, reflecting strong interest in next-generation technologies that enable faster and more controlled ablation procedures.

Market Dynamics: Opportunities, Restraints, and Strategic Considerations
Despite strong momentum, what challenges could limit market expansion? High capital costs associated with tumor ablation systems remain a key restraint, particularly in emerging economies where smaller healthcare facilities rely heavily on third-party reimbursements. As a result, the rising adoption of refurbished ablation systems—offered at a fraction of the cost of new equipment—poses a competitive challenge for manufacturers and may impact overall market growth.

Where are the most attractive opportunities emerging? Rapidly increasing healthcare expenditure in countries such as China, India, Brazil, and Mexico is creating favorable conditions for market expansion. Government initiatives to improve access to advanced healthcare services, combined with rising per-capita healthcare spending and improved reimbursement coverage, are expected to unlock significant growth potential in developing regions.

Request Sample Pages : https://www.marketsandmarkets.com/requestsampleNew.asp?id=142550258

Segment Insights: Where Demand Is Concentrated
By product type, generators held the largest market share in 2023, driven by increasing oncological surgeries and regulatory support for minimally invasive interventions. In terms of treatment mode, laparoscopic ablation is projected to register the highest CAGR due to benefits such as reduced pain, enhanced visualization, shorter hospital stays, and faster patient recovery.

From an application perspective, liver cancer dominated the market in 2023 and is expected to maintain strong growth through 2029, supported by increased adoption of image-guided therapies and growing funding for cancer research. By end user, hospitals and clinics accounted for the largest share, while specialized cancer care centers are anticipated to grow at the fastest rate during the forecast period.

Regional Outlook: Who Is Leading the Market
North America is expected to remain the largest regional market by 2029. The United States and Canada continue to benefit from advanced healthcare infrastructure, strong insurance coverage, favorable regulatory environments, and sustained investments in research and innovation. Strategic collaborations between industry players and healthcare providers further reinforce the region’s leadership position.

Competitive Landscape: How Market Leaders Are Positioning for Growth
The global tumor ablation market is moderately competitive, characterized by the presence of established multinational corporations and emerging manufacturers. Key players include Johnson & Johnson MedTech (US), Medtronic Plc (Ireland), Stryker Corporation (US), Varian Medical Systems, Inc. (US), Olympus (Japan), AngioDynamics, Inc. (US), Boston Scientific Corporation (US), IceCure Medical Ltd. (Israel), and Bioventus Inc. (US).

Market leaders are actively pursuing growth through product launches, strategic partnerships, acquisitions, and geographic expansion. In May 2023, Varian introduced the Isolis cryoprobe for its CryoCare systems, enhancing efficiency and procedural precision while reducing treatment time. In April 2023, AngioDynamics expanded its partnership with Cardiva to strengthen the distribution of oncology products across Europe.

Why This Market Signals Strategic Importance for Decision-Makers
For healthcare executives, medtech investors, and policymakers, the tumor ablation market represents a convergence of clinical necessity, technological innovation, and long-term growth potential. As cancer prevalence continues to rise and healthcare systems shift toward value-based, minimally invasive care models, tumor ablation technologies are positioned to play a critical role in shaping the future of oncology treatment.

For more information, Inquire Now!

Discover Connected Healthcare Market Opportunities:
Ablation Technology Market
Interventional Oncology Market
Cancer Biomarkers Market
AI in Oncology Market
Radiotherapy Market

Get access to the latest updates on Top Companies in Tumor Ablation and Tumor Ablation Market Size

About MarketsandMarkets™:

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.